NMAD — NOMAD Power Solutions Share News
0.000.00%
Last trade - 00:00Brief: LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI
Brief: Lixte, Netherlands Cancer Institute, And Oncode Institute To Expand Collaboration
Brief: Lixte Biotechnology Announced Passing Of Founder And Executive Chairman John Kovach
Brief: Lixte Biotechnology Receives Counter-Signed Termination Letter for License Agreement With Moffitt
Brief: Lixte Appoints Bas Van Der Baan As President And Chief Executive Officer
Brief: Lixte Biotechnology Holdings Inc Selling Stockholder Is Offering On A Resale Basis 583,334 Shares Of Co's Common Stock
Brief: Lixte Biotechnology Announces Closing Of $3.5 Mln Registered Direct Offering
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
Lixte Biotechnology Holdings plunges on $3.5 mln share offering
Brief: Lixte Biotechnology Announces Pricing Of $3.5 Mln Registered Direct Offering And Concurrent Private Placement
Brief: Lixte Biotechnology Holdings Regains Compliance With Nasdaq Continued Listing Requirements
Brief: LIXTE Biotechnology And The Spanish Sarcoma Group Enroll First Patient In A Phase 1B/2 Randomized Trial Of Doxorubicin +/- Lixte’S Lead Anti-Cancer Compound, Lb-100, In Advanced Soft Tissue Sarcomas
Brief: Lixte Biotechnology Announces 1-For-10 Reverse Stock Split Of Its Common Stock Effective On Pre-Market Opening On June 5, 2023
U.S. STOCKS ON THE MOVE-Microsoft, Manchester United, Coty
Brief: Lixte Biotechnology Announces Approval Of A Phase 1B/2 Randomized Trial Of Doxorubicin +/-Lb-100 In Advanced Soft Tissue Sarcomas To Be Conducted By The Spanish Sarcoma Group
Brief: Lixte Biotechnology Announces Appointment Of Bas Van Der Baan To Its Board
U.S. STOCKS ON THE MOVE-Lixte Biotechnology, Boeing Co, Worksport Ltd
NASDAQ RESUMED AT 01:58 PM